EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005
Clinical trial NCT04437368 · TERMINATED
Trial details
- NCT number
- NCT04437368
- Sponsor
- Gyroscope Therapeutics Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-26
- Primary completion
- 2024-04-05
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.